This male predominance reflects the overall demographics of the unrelated HCT registry, as 1586 (62%) of the 2569 patients without UBA1 testing were males, consistent with the known male predominance in MDS.41 This evidence concerns the gene UBA1 and myelodysplastic syndrome.